Barbara L. Brasier
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
JBTM mentioned in stock watchlists amid soft price action. Recent articles from Yahoo Finance have included JBT Marel in lists of stocks to monitor, often alongside other industrial names. These mentions highlight the company's presence in current market discussions despite recent price weakness. The stock is currently trading near its 52-week low, which provides context for why analysts are keeping a close eye on its performance.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Marzetti Expands Frozen Baked Bites Line. The Marzetti Company is expanding its frozen baked bites category, aiming to strengthen its position in the at-home snacking market. This move supports its broader strategy of offering convenient, ready-to-eat options. The company continues to be viewed as a stable value stock with solid fundamentals and a notable dividend yield.
Transaction History
| MOH | ▲ Buy | Grant | 304 | $55K | 10/1/2026 | View on chart |
| MOH | ▲ Buy | Grant | 237 | $55K | 7/1/2026 | View on chart |
| JBTM | ▲ Buy | Grant | 1,232 | $0 | 6/1/2026 | View on chart |
| MOH | ▲ Buy | Grant | 405 | $55K | 4/1/2026 | View on chart |
| MOH | ▲ Buy | Grant | 317 | $55K | 1/1/2026 | View on chart |
| MOH | ▲ Buy | Grant | 285 | $55K | 10/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 180 | $55K | 7/1/2025 | View on chart |
| JBTM | ▲ Buy | Grant | 1,418 | $0 | 6/2/2025 | View on chart |
| MOH | ▲ Buy | Grant | 168 | $55K | 4/1/2025 | View on chart |
| MOH | ▲ Buy | Grant | 189 | $55K | 1/1/2025 | View on chart |
| MZTI | ▲ Buy | Grant | 674 | $0 | 11/6/2024 | View on chart |
| MOH | ▲ Buy | Grant | 161 | $55K | 10/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 188 | $55K | 7/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 136 | $55K | 4/1/2024 | View on chart |
| MOH | ▲ Buy | Grant | 152 | $55K | 1/1/2024 | View on chart |
| MZTI | ▲ Buy | Grant | 695 | $0 | 11/8/2023 | View on chart |
| MOH | ▲ Buy | Grant | 168 | $55K | 10/1/2023 | View on chart |
| MOH | ▼ Sell | Open Market | 1,500 | $456K | 7/31/2023 | View on chart |
| MOH | ▲ Buy | Grant | 183 | $55K | 7/1/2023 | View on chart |
| JBTM | ▲ Buy | Grant | 1,258 | $0 | 5/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 206 | $55K | 4/1/2023 | View on chart |
| MOH | ▲ Buy | Grant | 167 | $55K | 1/1/2023 | View on chart |
| MZTI | ▲ Buy | Grant | 565 | $0 | 11/9/2022 | View on chart |
| MOH | ▲ Buy | Grant | 167 | $55K | 10/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 194 | $55K | 7/1/2022 | View on chart |
| JBTM | ▲ Buy | Grant | 1,145 | $0 | 5/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 162 | $55K | 4/1/2022 | View on chart |
| MOH | ▲ Buy | Grant | 173 | $55K | 1/1/2022 | View on chart |
| MZTI | ▲ Buy | Grant | 616 | $0 | 11/10/2021 | View on chart |
| MOH | ▲ Buy | Grant | 203 | $55K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Molina Healthcare Draws Value Investor Interest Amid Recent Pressure
Diamond Hill Capital has highlighted long-term value in Molina Healthcare following recent stock price pressure. This view is echoed by other market analyses questioning if the stock is a value play. The company is currently trading near its 52-week low, with an average analyst target of $209.12.
Molina Healthcare Draws Value Investor Interest Amid Recent Pressure. Diamond Hill Capital has highlighted long-term value in Molina Healthcare following recent stock price pressure. This view is echoed by other market analyses questioning if the stock is a value play. The company is currently trading near its 52-week low, with an average analyst target of $209.12.